Tapewire

Nasdaq · USD

SGRY

Surgery Partners, Inc.

Export transactions ↓
Tapewire entity
4534
SEC CIK
0001638833
Parsed reports
392

Last 12 months

Inside the activity.

2 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 2026012
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 17, 2017 Filed Mar 20, 2017 23:39 UTC
Crysel JohnGroup Pres., National Group
Tax withholdingCommon Stock 1,350 $19.90 $26,865.00
Disclosure

SEC source: 0000904454-17-000265 · edgar.xml · nonDerivative · entry 1

Crysel John · CIK 0001650622 · Group Pres., National Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,247

F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 17, 2017 of restricted stock that was granted to the Reporting Person on March 17, 2016.

Read SEC document
March 17, 2017 Filed Mar 20, 2017 23:36 UTC
Dean DennisSenior VP & Controller
Tax withholdingCommon Stock 1,394 $19.90 $27,740.60
Disclosure

SEC source: 0000904454-17-000263 · edgar.xml · nonDerivative · entry 1

Dean Dennis · CIK 0001650312 · Senior VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,203

F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 17, 2017 of restricted stock that was granted to the Reporting Person on March 17, 2016.

Read SEC document
March 17, 2017 Filed Mar 20, 2017 23:33 UTC
Baldock JenniferSr. VP, Gen Couns. & Sec.
Tax withholdingCommon Stock 1,392 $19.90 $27,700.80
Disclosure

SEC source: 0000904454-17-000261 · edgar.xml · nonDerivative · entry 1

Baldock Jennifer · CIK 0001650314 · Sr. VP, Gen Couns. & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,047

F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 17, 2017 of restricted stock that was granted to the Reporting Person on March 17, 2016.

Read SEC document
March 17, 2017 Filed Mar 20, 2017 23:31 UTC
Sparks TeresaExecutive VP & CFO
Tax withholdingCommon Stock 2,838 $19.90 $56,476.20
Disclosure

SEC source: 0000904454-17-000259 · edgar.xml · nonDerivative · entry 1

Sparks Teresa · CIK 0001650335 · Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,556

F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 17, 2017 of restricted stock that was granted to the Reporting Person on March 17, 2016.

Read SEC document
March 09, 2017 Filed Mar 13, 2017 22:30 UTC
Baldock JenniferSr. VP, Gen Couns. & Sec.
GrantCommon Stock 4,456 $0.00 $0.00
Disclosure

SEC source: 0000904454-17-000253 · edgar.xml · nonDerivative · entry 1

Baldock Jennifer · CIK 0001650314 · Sr. VP, Gen Couns. & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,439

Read SEC document
March 09, 2017 Filed Mar 13, 2017 22:03 UTC
Dean DennisSenior VP & Controller
GrantCommon Stock 4,456 $0.00 $0.00
Disclosure

SEC source: 0000904454-17-000251 · edgar.xml · nonDerivative · entry 1

Dean Dennis · CIK 0001650312 · Senior VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,597

Read SEC document
March 09, 2017 Filed Mar 13, 2017 21:59 UTC
Crysel JohnGroup Pres., National Group
GrantCommon Stock 4,456 $0.00 $0.00
Disclosure

SEC source: 0000904454-17-000249 · edgar.xml · nonDerivative · entry 1

Crysel John · CIK 0001650622 · Group Pres., National Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,597

Read SEC document
March 09, 2017 Filed Mar 13, 2017 21:56 UTC
Sparks TeresaExecutive VP & CFO
GrantCommon Stock 7,427 $0.00 $0.00
Disclosure

SEC source: 0000904454-17-000247 · edgar.xml · nonDerivative · entry 1

Sparks Teresa · CIK 0001650335 · Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,394

Read SEC document
March 09, 2017 Filed Mar 13, 2017 21:54 UTC
Doyle Michael ThomasDirector · Chief Executive Officer
GrantCommon Stock 22,281 $0.00 $0.00
Disclosure

SEC source: 0000904454-17-000245 · edgar.xml · nonDerivative · entry 1

Doyle Michael Thomas · CIK 0001650454 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,992,968

Read SEC document
October 03, 2016 Filed Oct 5, 2016 21:49 UTC
Degala SarathChief Development Officer
Disposition to issuerCommon Stock 17,825 $0.00 $0.00
Disclosure

SEC source: 0000904454-16-001474 · edgar.xml · nonDerivative · entry 1

Degala Sarath · CIK 0001675472 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 30, 2016 Filed Sep 30, 2016 23:40 UTC GrantStock Option (Right to Buy) · Derivative 4,199 $0.00 Strike: $20.24 $0.00
Disclosure

SEC source: 0000904454-16-001465 · edgar.xml · derivative · entry 1

DeLuca Teresa · CIK 0001685627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,199

Underlying: Common Stock · 4,199 shares

Expires 2026-09-30

F1 · derivative.exercise_date: The option vests annually over a three year period, with the first one-third vesting on 9/30/2017.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.